TY - JOUR A1 - John, Vini A1 - Kotze, Leigh A. A1 - Ribechini, Eliana A1 - Walzl, Gerhard A1 - Du Plessis, Nelita A1 - Lutz, Manfred B. T1 - Caveolin-1 controls vesicular TLR2 expression, p38 signaling and T cell suppression in BCG infected murine monocytic myeloid-derived suppressor cells JF - Frontiers in Immunology N2 - Monocytic myeloid-derived suppressor cells (M-MDSCs) and granulocytic MDSCs (G-MDSCs) have been found to be massively induced in TB patients as well in murine Mtb infection models. However, the interaction of mycobacteria with MDSCs and its role in TB infection is not well studied. Here, we investigated the role of Cav-1 for MDSCs infected with Mycobacterium bovis Bacille-Calmette-Guerín (BCG). MDSCs that were generated from murine bone marrow (MDSCs) of wild-type (WT) or Cav1\(^{−/−}\) mice upregulated Cav-1, TLR4 and TLR2 expression after BCG infection on the cell surface. However, Cav-1 deficiency resulted in a selective defect of intracellular TLR2 levels predominantly in the M-MDSC subset. Further analysis indicated no difference in the phagocytosis of BCG by M-MDSCs from WT and Cav1\(^{−/−}\) mice or caveosome formation, but a reduced capacity to up-regulate surface markers, to secrete various cytokines, to induce iNOS and NO production required for suppression of T cell proliferation, whereas Arg-1 was not affected. Among the signaling pathways affected by Cav-1 deficiency, we found lower phosphorylation of the p38 mitogen-activated protein kinase (MAPK). Together, our findings implicate that (i) Cav-1 is dispensable for the internalization of BCG, (ii) vesicular TLR2 signaling in M-MDSCs is a major signaling pathway induced by BCG, (iii) vesicular TLR2 signals are controlled by Cav-1, (iv) vesicular TLR2/Cav-1 signaling is required for T cell suppressor functions. KW - myeloid-derived suppressor cell (MDSC) KW - caveolin-1 (Cav-1) KW - TLR2 KW - TLR4 KW - BCG KW - T cell suppression Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-195528 SN - 1664-3224 VL - 10 IS - 2826 ER - TY - JOUR A1 - Grimmig, Tanja A1 - Moench, Romana A1 - Kreckel, Jennifer A1 - Haack, Stephanie A1 - Rueckert, Felix A1 - Rehder, Roberta A1 - Tripathi, Sudipta A1 - Ribas, Carmen A1 - Chandraker, Anil A1 - Germer, Christoph T. A1 - Gasser, Martin A1 - Waaga-Gasser, Ana Maria T1 - Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer JF - International Journal of Molecular Sciences N2 - Toll like receptor (TLR) signaling has been suggested to play an important role in the inflammatory microenvironment of solid tumors and through this inflammation-mediated tumor growth. Here, we studied the role of tumor cells in their process of self-maintaining TLR expression independent of inflammatory cells and cytokine milieu for autoregulative tumor growth signaling in pancreatic cancer. We analyzed the expression of TLR2, -4, and -9 in primary human cancers and their impact on tumor growth via induced activation in several established pancreatic cancers. TLR-stimulated pancreatic cancer cells were specifically investigated for activated signaling pathways of VEGF/PDGF and anti-apoptotic Bcl-xL expression as well as tumor cell growth. The primary pancreatic cancers and cell lines expressed TLR2, -4, and -9. TLR-specific stimulation resulted in activated MAP-kinase signaling, most likely via autoregulative stimulation of demonstrated TLR-induced VEGF and PDGF expression. Moreover, TLR activation prompted the expression of Bcl-xL and has been demonstrated for the first time to induce tumor cell proliferation in pancreatic cancer. These findings strongly suggest that pancreatic cancer cells use specific Toll like receptor signaling to promote tumor cell proliferation and emphasize the particular role of TLR2, -4, and -9 in this autoregulative process of tumor cell activation and proliferation in pancreatic cancer. KW - tumor growth KW - TLR2 KW - TLR4 KW - TLR9 KW - pancreatic cancer KW - inflammation Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-165743 VL - 17 IS - 12 ER - TY - THES A1 - Wenzel, Jens T1 - Regulation of TLR-induced macrophage responses by cytoskeleton-associated phosphoproteins T1 - Regulation der Antwort von Makrophagen auf TLR-Stimulation durch Zytoskelett-assoziierte Phosphoproteine N2 - Toll-like receptors (TLR) are pattern recognition receptors (PRR) by which macrophages (MØ) sense pathogen-associated molecular patterns (PAMPs). The recognition of lipopolysaccharide (LPS), the PAMP of gram negative bacteria, by TLR4 triggers signaling cascades and leads to the pro-inflammatory activation of the cells. A recent quantitative and kinetic analysis of the phosphoproteome of LPS-activated primary macrophages highlighted the cytoskeleton as a cell compartment with an enriched protein phosphorylation. In total 44 cytoskeleton-associated proteins were regulated by this post-translational modification and thus might be involved in the control and regulation of key macrophage functions like spreading, motility and phagocytosis. To investigate the control of cytoskeleton-associated cell functions by TLR4 activation, we first developed a method to quantitatively measure the spreading response of bone marrow MØ after stimulation with LPS. Fluorescence microscopy was used for cell imaging and visualisation of the MØ contact area. In collaboration with the Fraunhofer Institute Erlangen, we developed and validated a software tool for the semi-automated segmentation and quantitation of MØ fluorescence microscopy data, which allowed fast, robust and objective image analysis. Using this method, we observed that LPS caused time-dependent spreading, which was detectable after 1-2 h and maximal after 24 h. Next, the impact of genetic or pharmacological inhibition of known TLR signaling components was investigated. Deficiency in the adapter protein MYD88 strongly reduced spreading activity at the late time points, but had no impact early after LPS-stimulation. A similar effect was observed upon pharmacological inhibition of ERK1/2 signaling, indicating that ERK1/2 mediates MYD88-dependent MØ spreading. In contrast, MØ lacking the MAPK p38 were impaired in the initial spreading response but responded normally 8-24 h after stimulation. The genetic deletion of the MAPK phosphatases DUSP1 and DUSP16 resulted in impaired late spreading, corroborating the essential role for functional MAPK signaling in TLR4-driven MØ spreading. To identify the contribution of other cytoskeletal phosphoproteins to MØ spreading, siRNA knockdown of selected candidate genes in primary murine MØ was employed and combined with automated quantitative image analysis. These experiments revealed a functional role for the Myosins MYO1e and MYO1f in MØ spreading. These motor proteins are strongly phosphorylated in LPS-activated MØ. Because of their ability to simultaneously bind to actin filaments and cell membrane or other proteins, we investigated their role in phagocytosis, cytokine production and antigen presentation. Phagocytosis and killing of bacteria were not affected in Myo1e-/- macrophages. However, MYO1e plays a role in chemokine secretion and antigen presentation processes. MCP1 (CCL2) release was selectively increased in Myo1e-deficient MØ and dendritic cells (DC), while cytokine secretion was unaffected. Furthermore, macrophages and DCs lacking MYO1e showed lower levels of MHC-II on the cell surface. However, mRNA levels of CCL2 and of MHC-II were unaltered. These data suggest a role for MYO1e in the transport of selected chemokines and of MHC-II molecules to the cell surface. MHC-II-restricted antigen presentation assays revealed an impaired capacity of macrophages and DC lacking MYO1e to stimulate antigen-specific T cells, suggesting that the reduced MHC-II expression is functionally relevant. Taken together, in this study first a quantitative image analysis method was developed which allows the unbiased, robust and efficient investigation of the macrophage spreading response. Combination of this method with siRNA knockdown of selected cytoskeleton-associated phosphoproteins led to the identification of MYO1e and MYO1f as regulators of macrophage spreading. Furthermore, we identified MYO1e in MØ and DC to be essential for the intracellular transport of CCL2 and MHC-II to the cell surface and for optimal stimulation of antigen-specific CD4 T cells. N2 - Toll-like Rezeptoren (TLR) sind Mustererkennungsrezeptoren (PRR) durch die Makrophagen (MØ) pathogen-assoziierte molekulare Muster (PAMPs) erkennen. Die Erkennung von Lipopolysacchariden (LPS), dem PAMP gramnegativer Bakterien, durch TLR4 löst Signalkaskaden aus, die zu einer pro-inflammatorischen Aktivierung der Zellen führen. Eine quantitative und kinetische Analyse des Phosphoproteoms LPS-aktivierter primärer Makrophagen identifizierte das Zytoskelett als ein Zellkompartiment mit gesteigerter Proteinphosphorylierung. Insgesamt wurden 44 Zytoskelett-assoziierte Proteine identifiziert, die durch diese post-translationale Modifikation reguliert wurden und demzufolge an der Regulation wichtiger Zellfunktionen von Makrophagen wie Spreading, Motilität und Phagozytose beteiligt sein könnten. Um die Kontrolle Zytoskelett-vermittelter Zellfunktionen nach TLR4 Aktivierung zu untersuchen, entwickelten wir zunächst eine Methode zur quantitativen Messung der Spreadingantwort von Knochenmarksmakrophagen nach LPS Stimulation. Die Visualisierung der Zellen sowie ihrer Kontaktfläche erfolgte hierbei mittels Fluoreszenzmikroskopie. Für eine schnelle, robuste und objektive Analyse der Fluoreszenzaufnahmen entwickelten und validierten wir in Kollaboration mit dem Fraunhofer Institut in Erlangen eine Software zur halbautomatischen Segmentierung und Quantifizierung der Kontaktfläche. Unter Verwendung dieser Methode konnte eine zeitabhängige LPS-induzierte Zunahme der Zellkontaktfläche beobachtet werden, die nach 1-2 Stunden detektierbar war und ein Maximum nach 24 Stunden erreichte. Durch den Einsatz pharmakologischer Inhibitoren sowie genetisch veränderter Zellen wurde anschließend der Einfluss bekannter TLR4-Signalwegkomponenten untersucht. Die genetische Defizienz des Adapterproteins MYD88 führte hierbei zu einer stark reduzierten Spreadingaktivität der Zellen während der späten LPS Stimulationsphase, wohingegen das initiale Spreading nicht beeinflusst wurde. Ein vergleichbarer Effekt konnte unter Verwendung eines pharmakologischen Inhibitors zur Hemmung des ERK1/2 Signalweges identifiziert werden. Diese Beobachtungen deuten darauf hin, dass ERK1/2 für die Weiterleitung des MYD88 vermittelten Spreading notwendig ist. Im Gegensatz dazu wurde in p38-defizienten Makrophagen ein beeinträchtigtes initiales Spreading beobachtet, wohingegen das späte Spreading nach 8 – 24 Stunden nicht beeinflusst war. Die genetische Deletion der MAPK Phosphatasen DUSP1 und DUSP16 resultierte ebenfalls in einer Minderung des späten Spreadings, ebenfalls ein Hinweis auf die essentielle Rolle funktioneller MAPK Signalwege. Um die Beteiligung weiter Zytoskelett-Phosphoproteine am Zellspreading zu identifizieren, wurde die Expression ausgewählter Kandidatengene in primären Makrophagen mittels spezifischer siRNA unterdrückt und das Zellspreading mit Hilfe der entwickelten Software quantifiziert. Diese Versuche zeigten eine funktionelle Rolle der Myosine MYO1e und MYO1f. Diese Motorproteine weisen ebenfalls eine starke Phosphorylierung nach LPS Stimulation auf. Aufgrund ihrer Eigenschaft simultan mit Aktinfilamenten und Zellmembranen sowie anderen Proteinen zu interagieren, untersuchten wir ihre Rolle während der Phagozytose, Zytokinfreisetzung und Antigenpräsentation. Obwohl Myo1e defiziente Makrophagen keine Beeinträchtigung der Phagozytose oder Abtötung von Bakterien aufwiesen, spielte das Motorprotein eine wichtige Rolle in der Chemokinfreisetzung und Antigenpräsentation. Interessanterweise war die Sekretion des Chemokins MCP1 (CCL2) in Myo1e-defizienten Makrophagen und dendritischen Zellen (DC) selektiv erhöht, während die Zytokinfreisetzung unbeeinträchtigt war. Des Weiteren wiesen Myo1e KO Makrophagen und DC eine reduzierte MHC-II Oberflächen-Expression auf, obwohl die MHC-II als auch die CCL2 Transkription auf mRNA Ebene nicht beeinflusst war. Diese Daten legen nahe, dass MYO1e während des Transports bestimmter Chemokine, sowie von MHC-II zur Zelloberfläche eine wichtige Rolle spielt. Zudem zeigten Myo1e KO Makrophagen und DC in einem MHC-II-abhängigen Antigenpräsentationsassay eine abgeschwächte Fähigkeit zur Antigen-spezifischen T-Zell Aktivierung, was die funktionelle Relevanz der reduzierten Expression von MHC-II nahelegt. Zusammenfassend wurde in dieser Studie zunächst eine Methode zur quantitativen Bildanalyse entwickelt, welche eine unvoreingenommene, robuste und effiziente Untersuchung des Spreadings von Makrophagen erlaubte. Die Kombination dieser Methode mit dem spezifischen siRNA Knockdown ausgewählter Zytoskelett-assoziierter Phosphoproteine führte zur Identifizierung von MYO1e und MYO1f als wichtige Regulatoren dieser Zellfunktion. Darüber hinaus konnte in Makrophagen und DC eine essentielle Rolle für MYO1e im intrazellulären Transport von CCL2 und MHC-II an die Zelloberfläche identifiziert werden, sowie dessen Notwendigkeit für eine vollständige Aktivierung antigen-spezifischer CD4 T Zellen. KW - Toll-like-Rezeptoren KW - Makrophage KW - Phosphoproteine KW - Zellskelett KW - macrophage KW - cytoskeleton KW - phosphorylation KW - TLR4 Y1 - 2014 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-98843 ER - TY - JOUR A1 - Hedrich, Christian M. A1 - Hofmann, Sigrun R. A1 - Pablik, Jessica A1 - Morbach, Henner A1 - Girschick, Hermann J. T1 - Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO) JF - Pediatric Rheumatology N2 - Sterile bone inflammation is the hallmark of autoinflammatory bone disorders, including chronic nonbacterial osteomyelitis (CNO) with its most severe form chronic recurrent multifocal osteomyelitis (CRMO). Autoinflammatory osteopathies are the result of a dysregulated innate immune system, resulting in immune cell infiltration of the bone and subsequent osteoclast differentiation and activation. Interestingly, autoinflammatory bone disorders are associated with inflammation of the skin and/or the intestine. In several monogenic autoinflammatory bone disorders mutations in disease-causing genes have been reported. However, regardless of recent developments, the molecular pathogenesis of CNO/CRMO remains unclear. Here, we discuss the clinical presentation and molecular pathophysiology of human autoinflammatory osteopathies and animal models with special focus on CNO/CRMO. Treatment options in monogenic autoinflammatory bone disorders and CRMO will be illustrated. KW - bisphosphonate treatment KW - IL-10 expression KW - TNF-α KW - IL-10 KW - inflammation KW - bone KW - CRMO KW - CNO KW - DIRA KW - PAPA KW - Majeed-Syndrome KW - disease KW - deficiency KW - pediatric patients KW - treatment KW - TLR4 KW - PAPA syndrome KW - hypertrophic osteodystrophy KW - chronic nonbacterial osteomyelitis KW - congenital dyserythropoietic anemia Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-125694 SN - 1546-0096 VL - 11 IS - 47 ER - TY - JOUR A1 - Hedrich, Christian M. A1 - Hofmann, Sigrun R. A1 - Pablik, Jessica A1 - Morbach, Henner A1 - Girschick, Hermann J. T1 - Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO) JF - Pediatric Rheumatology N2 - Sterile bone inflammation is the hallmark of autoinflammatory bone disorders, including chronic nonbacterial osteomyelitis (CNO) with its most severe form chronic recurrent multifocal osteomyelitis (CRMO). Autoinflammatory osteopathies are the result of a dysregulated innate immune system, resulting in immune cell infiltration of the bone and subsequent osteoclast differentiation and activation. Interestingly, autoinflammatory bone disorders are associated with inflammation of the skin and/or the intestine. In several monogenic autoinflammatory bone disorders mutations in disease-causing genes have been reported. However, regardless of recent developments, the molecular pathogenesis of CNO/CRMO remains unclear. Here, we discuss the clinical presentation and molecular pathophysiology of human autoinflammatory osteopathies and animal models with special focus on CNO/CRMO. Treatment options in monogenic autoinflammatory bone disorders and CRMO will be illustrated. KW - TNF-α KW - PAPA KW - DIRA KW - Majeed KW - CNO KW - CRMO KW - bone KW - inflammation KW - IL-10 KW - treatment KW - TLR4 Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-132456 VL - 11 IS - 47 ER -